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Abstract
Background: With the rapid advancement of array-based genotyping techniques, genome-wide association studies
(GWAS) have successfully identified common genetic variants associated with common complex diseases. However,
it has been shown that only a small proportion of the genetic etiology of complex diseases could be explained by
the genetic factors identified from GWAS. This missing heritability could possibly be explained by gene-gene
interaction (epistasis) and rare variants. There has been an exponential growth of gene-gene interaction analysis for
common variants in terms of methodological developments and practical applications. Also, the recent
advancement of high-throughput sequencing technologies makes it possible to conduct rare variant analysis.
However, little progress has been made in gene-gene interaction analysis for rare variants.
Results: Here, we propose GxGrare which is a new gene-gene interaction method for the rare variants in the
framework of the multifactor dimensionality reduction (MDR) analysis. The proposed method consists of three steps;
1) collapsing the rare variants, 2) MDR analysis for the collapsed rare variants, and 3) detect top candidate interaction
pairs. GxGrare can be used for the detection of not only gene-gene interactions, but also interactions within a single
gene. The proposed method is illustrated with 1080 whole exome sequencing data of the Korean population in order
to identify causal gene-gene interaction for rare variants for type 2 diabetes.
Conclusion: The proposed GxGrare performs well for gene-gene interaction detection with collapsing of rare variants.
GxGrare is available at http://bibs.snu.ac.kr/software/gxgrare which contains simulation data and documentation.
Supported operating systems include Linux and OS X.
Keywords: Gene-gene interaction, Rare variant, Multifactor dimensionality reduction
Background
Looking beyond single genetic effects and the boundaries
of additive inheritance of single nucleotide polymorphisms
(SNPs), could better demonstrate biological pathways in-
volved in disease etiology [1]. Many assumed common
variants to provide sufficient explanation for common dis-
eases, so the focus of genome-wide association studies
(GWAS) have been set on evaluating common genetic
markers. Such approach is also known as the ‘common-
disease common-variants’ model, which states that com-
mon diseases are caused by common variants with minor
allele frequencies (MAFs) greater than 5% [2]. Although
the success of GWAS in common diseases provided some
convincing evidences, a large proportion of the genetic
heritability is left unresolved using the currently discov-
ered major genetic loci [3]. For instance, the result with 71
loci of a genome-wide meta-analysis explains only 23.2%
of the heritability of Crohn’s disease [4]. Such
shortcomings led to a phase of analyzing the rare variants,
genetic interactions, and environmental interactions.
Hence, more complex statistical methods had to be
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applied to detect genes with not only moderate or high ef-
fect size, but also small marginal effect towards phenotype
that interacts with each other.
In recent years, studies support the ‘common-disease
rare-variants’ hypothesis [5], which claims that complex
disorders are caused by multiple rare variants. As an ex-
ample, type 2 diabetes mellitus (T2D) is a complex disease
which is caused by both genetic composition and environ-
mental factors. The exact biochemical mechanism is yet
to be unveiled, however, though impairments in insulin
action and secretion certainly take parts. Unlike type 1
diabetes, T2D is characterized primarily by ‘insulin resist-
ance’, and a vast majority of this resistance is shown as de-
fects at the post receptor level [6]. Heterogeneity in
pathological and physiological symptoms of T2D leads to
a variety of complications such as coronary heart disease,
retinopathy, nephropathy, etc.
Due to rare variants having low frequencies and existing
in large number, traditional single-marker association tests
generally lack power in these variants. In recent studies, sev-
eral methods have been developed and categorized to one
of collapsing, similarity-based and distance-based methods.
Collapsing methods transform multiple variants in specific
regions of interest to a single new aggregated variable. Com-
bined Multivariate and Collapsing (CMC) method [7],
Weighted Sum (WS) test [8], Variable Threshold (VT) [9]
and GRANVIL [10] belong to this category and they show
better performance than others when variants in a region
have effects in the same direction (deleterious or protective)
and when there are a few non-causal variants in the region.
Similarity-based methods use a multi-locus genotypes simi-
larity among samples. Kernel-based adaptive cluster method
[11] and sequencing kernel-based association test (SKAT)
[12] belong to this category, and these methods are robust
to directions of variant effects and large proportion of non-
causal variants in a region. SKAT is extended to SKAT-O
[13] using weighted average of statistics of SKAT and
burden test. Distance-based methods use physical positions
of variants. IL-K [14], KERNEL [15] and CLUSTER [16]
belong to this category.
However, studies on gene-gene interaction (GGI) studies
using rare variants are scarce. We incorporate the multifac-
tor dimensionality reduction (MDR) method, which is
useful for “detecting and characterizing interactions in
common complex multifactorial disease” [17]. This is ap-
plicable even when the sample size is small or when the
dataset contains alleles in linkage disequilibrium. However,
the original MDR method had some limitations, and vari-
ous versions of improved methods were suggested, such as
the Odds ratio based MDR [18], Log-linear model-based
MDR [19], gene-based MDR [20], entropy-based GGI ana-
lysis algorithm (IGENT) [21], etc. Of these methods, a gen-
eralized version of MDR called GMDR [22], enables the
use of covariates and continuous phenotypes as the
dependent variable. Its basic idea is to substitute a score
statistic or some other quantitative measure, instead of dis-
ease status, while preserving the same reduction strategy.
To apply MDR in rare variant setting, we proposed
GxGrare that applied collapsing strategies in order to
summarize the genotype information to a more practical
score that can be used in the existing MDR methods.
We then compared the performances of our method
with that of the Summation of Partition Approach (SPA)
[23]. The SPA method has been proposed by Fan et al.
and it is a robust model-free method that is designed to
detect both marginal effects and effects due to gene-
gene and gene-environment interactions of rare variants.
The SPA method is one of the latest approaches, yet it
defines gene-gene interaction in a somewhat different
manner in that it measures the interaction between two
SNPs within a gene. Our simulation scheme includes
those from this paper.
Methods
In the methods section, we introduce a novel collapsing idea.
Then, we briefly review the GMDR method and evaluation
measures. Last, we explain our proposed analysis steps.
Collapsing methods
Since rare variants are hard to analyze by traditional
single-marker association methods, we propose a novel
collapsing method. In our collapsing method, the geno-
types of SNPs in a gene are merged with a new genotype
of the gene with the SNPs’ weights, and we propose novel
three weighting schemes for individual SNPs: MAF-based,
functional region-based, and effect-based collapsing. The
common collapsing strategy is shown in Fig. 1.
Figure 1 shows an illustrative example that consists of 4
case and 4 control samples. In the gene k, there are five
SNPs (S1~S5) and their weight values (ws1~ws5). Each
sample has five genotypes that represent the number of
mutations in a SNP. First, we calculate the weight of each
SNP by one of the three proposed weighting schemes.
Second, we multiply genotype values and corresponding
weights and then sum them for each sample such as ‘ws1
+ ws3’ for case1. Last, summed values are transformed to
one of two or three values by a binning step (gray arrow).
The number of bins and threshold values for the binning
step depend on the weighting scheme.
In MAF-based collapsing, the weight of SNPs inside the
genes are decided based on their MAFs; MAF< 0.01
(weight: 1) and the rest (weight: 0). This weighting scheme
is designed based on the hypothesis that “disease-promot-
ing variants should be rare” [24]. We tested two kinds of
number of bins, two and three. In the two bins test, the
collapsed genotypes are decided by whether summed values
are zero (collapsed genotype: 0) or not (collapsed genotype:
1). In other words, genes are divided into two with
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(collapsed genotype: 1) or without (collapsed genotype: 0)
rare variants groups. In the three bins test, genes are di-
vided into three groups: genes without rare variants, genes
with a single rare variant and genes with two or more rare
variants groups.
For the functional region-based collapsing, the variants in
a gene are collapsed to their annotated functional regions,
such as coding region, splice junctions, etc. Genes with rare
variants in a less functional region, such as intron region,
have low weight such as 0, and 1 otherwise. For the simpli-
city of weighting scheme, we use two values 0 or 1 as weight
values in our tests. In other words, all variants would be
given the same weight, 1, and a variant in functional region
would be given its SNP count through an indicator function,
less meaningful variants would be given 0. The sum of the
output SNP counts of the indicator function would be com-
pared to a threshold of 0. This reflects the importance of
gene structure and region specific variants. The information
of functional region can be derived from annotation scores
of SNPeff [25], PolyPhen2 [26] and SIFT [27]. However,
scores of PolyPhen2 and SIFT have poor coverage (only 60
and 81% of human proteome, respectively). Therefore, a
conservation score of variants can be an alternative weight
as functional region information additionally, under the
claims of Ng and Henikoff, authors of SIFT [27], that “dis-
ease-causing mutations are more likely to occur at positions
that are conserved throughout evolution.” The conservation
scores calculated from PhastCons [28] and phyloP [29] are
utilized. Among various candidates of functional region in-
formation, we used the regional annotation tag information
of SNPeff that variants are pooled into four categories highly
deleterious, moderately deleterious, less deleterious and
others. We set weights of variants as 1 in highly and moder-
ately categories or 0 for the other variants.
Aforementioned two weighting schemes are based on the
unidirectional mechanism that mutations may increase dis-
ease risks. However, even if it has a low chance of happening,
mutations can have protective effects at diseases occurrences.
Therefore, we proposed the effect-based scheme based on a
bidirectional (deleterious and protective effects) mechanism.
The effect-based method collapses the variants to their ac-
cording genes based on values of information gain (IG)
under assumptions of both effect direction (deleterious and
protective). IG value is one of the association measures based
on information theory and we elaborated IG in the following
2.3 Evaluation Measures section. First, two IG values of a
variant are calculated for deleterious and protective effect as
shown in Fig. 2. These two IG values are calculated by num-
ber of mutations in the case group and control group re-
spectively. Second, variants are selected sequentially by order
of IG values similar to the forward selection approach and
IG value of selected variants combination is calculated.
The different number of variants (T1~T5 in Fig. 2) are com-
pared by their IG values and the number of variants is deter-
mined the maximum IG value.
Review of generalized multifactor dimensionality
reduction (GMDR)
MDR method is proposed for gene-gene interaction detec-
tion in case-control study. The key idea of MDR is the re-
duction method from multi-locus genotypes into one of
high or low risk groups. Since MDR is a non-parametric
approach, the best SNP combination is selected by evalu-
ation measures such as balanced accuracy (BA) and cross
validation consistency (CVC) in the cross validation pro-
cedure. Among many extensions of MDR, GMDR is ex-
tended for covariate adjustments and to deal with not
only quantitative phenotypes such as a body mass index
(BMI) but also qualitative phenotypes such as disease
status.
Since the purpose of GMDR is to detect interactions of
SNP combinations with covariate adjustments for both
quantitative and qualitative phenotypes, it consists of two
steps. In the first step, residuals of each sample are
Fig. 1 Illustration of the collapsing strategy shared in all three proposed methods
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calculated using a model fitting of the generalized linear
model (GLM) with covariates and without genotype infor-
mation. In the second step, residuals are used as geno-
types in MDR. For an illustrative purpose, an example of
GMDR is shown Fig. 3. In Fig. 3, two covariates (sex and
age) are considered in a case-control study. The first step
is a GLM fitting in Fig. 3 and the residual values are calcu-
lated by the fitted model. And then, the residual values are
pooled into groups by genotype values of a SNP combin-
ation as shown in Fig. 3. In this example, two SNPs (S1
and S2) make the SNP combination and ‘A’ designates
major allele of the S1, ‘a’ designates minor allele of the S1,
‘B’ designates major allele of S2 and ‘b’ designates minor
allele of S2. In this step, residuals are grouped by own sign
and summed respectively in each genotype combination.
In Fig. 3, the left blue bars represent the sum of plus
signed residuals and the right orange bars represents the
sum of minus signed residuals in each genotype combin-
ation. And then, each cell is assigned a high (H) or low (L)
risk group by a comparison of heights between the blue
bar and the orange bar. These two steps (GLM model
fitting and dimensionality reduction) are performed for
each SNP combination and compared by evaluation mea-
sures under the cross-validation structure. For example, in
Fig. 3 An example of GMDR
Fig. 2 Illustration of the effect-based collapsing scheme
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10-fold cross-validation, data is divided into 10 subsets. A
GMDR model is trained using 9/10 among subsets, and
then the GMDR model is tested to remained 1/10 subset.
We use collapsed genotypes of genes as genotypes of
SNPs in GMDR method. Since, a collapsed genotype of
a gene has two (0/1) or three (0/1/2) possible values, the
size of a contingency table in the dimensionality reduc-
tion step, can be the same or reduced, but the final two-
way contingency table has the same size.
Evaluation measures
Since the results of GMDR method, as other methods, de-
pend on evaluation measures, different variants combina-
tions can be selected sometimes by selection of evaluation
measures. Therefore, we concerned two popular MDR
evaluation measures BA and CVC, and an information
theory based measure IG for case-control studies.
Many extensions of MDR for case-control studies use BA
and CVC as evaluation measures. BA defined as an average
of sensitivity and specificity, is proposed by Velez et al. to
measure the performance in MDR methods [30]. IG, also
known as Kullback-Leibler divergence, proposed by Mitchell
et al., is defined as IG(T, g) =H(T)−H(T| g), (where H is en-
tropy). In genetic association studies, T can be a phenotype
such as disease status and g can be a genetic variant such as
a SNP. In this case, entropy of T H(T) represents the uncer-
tainty of T (H(T) is 1 on a balance case-control study.) and
H(T| g) represents remained uncertainty under known g.
Therefore, IG(T, g) represents the amount of uncertainty re-
duction of T by g. IG is sometimes called mutual information
and it corresponds to a gamma distribution asymptotically
[31]. IG(T, g) holds the meaning of difference between mar-
ginal and conditional entropy and is from information theory
and machine learning that can be used as an evaluation
measure. In a dataset, with given disease information and
collapsed genotype information, the conditional and mar-
ginal entropy can be easily calculated.
CVC, along with the BA, has been used multiple times
in MDR studies; it is defined as the number of times that
a SNP combination is identified as the best combination,
from any measures (i.e. BA or IG), across the 10 CV data-
sets. A general step of 10-fold CV is done by splitting the
full dataset into 10, and using 1/10 as testing set and
others as training set. This way, ten different training sets
and testing sets can be analyzed. We use weighted CVC
(WCVC) [32] in T2D data analysis to decide the optimal
order interactions for advanced analysis.
Proposed GGI analysis method for rare variants (GxGrare)
Figure 4 explains the steps involved in the proposed
method. In the collapsing step, one among three collaps-
ing schemes is selected, and then information of variants
on a gene are aggregated to a new collapse genotype
under the selected collapsing scheme. We tested three
collapsing schemes and compared the results.
In the GMDR step, first, residuals of samples are cal-
culated through GLM model fitting with covariates. Sec-
ond, H or L value is assigned for each combination of
collapsed genotype by a distribution of residuals and
then dimensionality is reduced by MDR manner. The
best SNP combinations are selected by the evaluation
measures under the cross-validation structure.
The selected SNP combinations in the results of
GMDR step, are analyzed in the interpretation step. Ba-
sically, the interaction of the selected SNP combination
is represented through visualization. For an advanced
analysis, interactions can be shown as a network dia-
gram. Biological meaning of SNP combinations and its
interaction may be confirmed or interpreted by literature
reviews. More details of interpretation steps are shown
in the result section.
Results
First, we compared our proposed method using optional
selections (collapsing schemes and evaluation measures)
with the summation of partition approach (SPA) in terms
of power to detect causal variants under various simulation
settings. Second, we checked type I error rates of our pro-
posed method and SPA using a simulation dataset without
causal variants. Then, we applied the proposed method
with MAF-based collapsing to T2D data to detect interac-
tions using rare variants and interpreted the results.
Results of simulation
The statistical efficiency of the proposed method was evalu-
ated through a set of gene-gene interaction simulation set-
tings. We incorporated Marchini’s four interaction models
for rare variants: multiplicative, additive, maximum and
minimum threshold effects models [33]. The genotypes
were generated under HWE with 20 rare SNPs in each
gene. As for the phenotypes, 2 cases were considered; GGI
with and without marginal effects. Also, to handle the di-
rections of SNP effects, deleterious vs. protective, we con-
sidered unidirectional and bidirectional conditions. Lastly,
different weighting schemes were also applied to the phe-
notypes to reflect the characteristics of real data. Here,
MAF based and conservation score based weighting
schemes have been considered, and various combination of
the above parameters have been used for simulation
models. The simulation settings are summarized in Table 1.
We considered ten simulation settings for this study and
evaluated the power. Power is defined as a proportion of
causal genes detection among 100 replicates for five differ-
ent sample sizes (300, 600, 1000, 1500, and 2000) with 10
effective SNP ratios (0.1~ 1.0) on each simulation setting.
Among the results of 10 simulation settings, we repre-
sented the results of simulation 1 in Fig. 5.
Kwon et al. BMC Systems Biology 2018, 12(Suppl 2):19 Page 25 of 130
In Fig. 5, the y-axis represents the power of each method
and the x-axis represents the effective SNP ratio. In the le-
gend of Fig. 5, ‘SPA’ is referring to the SPA method,
‘MDRcol_’ to our proposed method, ‘MAF’ to MAF-based
collapsing, ‘func’ to functional region-based collapsing and
‘effect’ to effect-based collapsing. ‘IG’ and ‘BA’ in paren-
theses mean information gain and balanced accuracy, re-
spectively, as evaluation measures. Different methods were
tested in the dichotomous trait (case/control). As expected,
powers of all methods show that patterns increase as sam-
ple size and effect SNP ratio increase. These trends are con-
sistently shown in the results of the other simulations. In
terms of comparison among collapsing methods, MAF-
based collapsing scheme shows higher power than other
collapsing schemes. IG shows higher power than BA on
same collapsing schemes. These trends are shown in some
results of the other simulations, but powers of different col-
lapsing methods and evaluation measures are similar at the
same sample size and effective SNP ratio. The effective
SNP ratio is defined as the proportion of non-zero weighted
SNPs in a region. SPA shows lower power than that of
MAF-based collapsing with information gain (‘MDRcol_-
MAF(IG)’ in Fig. 5) and similar with the other methods.
Overall, MAF-based collapsing with information gain
(‘MDRcol_MAF(IG)’ in Fig. 5) show the highest power in
many cases and similar power with the others in remained
cases. GxGrare outperformed SKAT and SPA in the
simulations without weight or with MAF weight. In
the simulations with conservation weight, GxGrare
showed similar performance with SKAT and SPA
(Additional file 1: Figure S1-S9).
The type I error, the incorrect rejection of a true null hy-
pothesis, has been measured with 1000 repeats and at the
5% significance level. In the results, all testing methods
Table 1 Simulation settings
Index Simulation settings
Weight Effect model Conditions
1 No weight Only interaction effect Unidirectional
2 No weight Interaction + marginal effect Unidirectional
3 No weight Only interaction effect Bidirectional
4 MAF weight Only interaction effect Unidirectional
5 CONS weight (0.5) Only interaction effect Unidirectional
6 CONS weight (0.8) Only interaction effect Unidirectional
7 CONS weight (1.0) Only interaction effect Unidirectional
8 CONS weight (0.5) Interaction + marginal effect Unidirectional
9 CONS weight (0.75) Interaction + marginal effect Unidirectional
10 CONS weight (1.0) Interaction + marginal effect Unidirectional
Fig. 4 Three steps in the proposed method
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show about 5% (4.4%~ 5.5%) type I error rates. We
observed that the type I error has been well controlled.
Application to real data (T2D)
We employed a partial set from a study with ~ 13 K indi-
viduals from multiple ancestries as part of five whole-
exome sequencing studies: the Type 2 Diabetes Genetic
Exploration by Next-generation sequencing in multi-
Ethnic Samples (T2D-GENES) study. Here, we utilized
the Korean subjects in the project, which consists of 1072
individuals and 488,457 autosomal variants.
After quality control with the Hardy-Weinberg equi-
librium test and filtering for missing ratio of greater than
0.05 and for MAF of less than 0.01 (rare variants),
414,193 (84.8%) variants remained for the analysis.
Gene-based results exhibit no significant genes to be
found in relation to T2D using this subset. For adjusting
of confounding effects of experimental variables, we use
age, sex, BMI, and recruitment area as covariates be-
cause of two reasons; Age, sex, and BMI are well-known
factors that have association with T2D and two recruit-
ment areas (Ansan and Ansung cohorts) are involved in
the study design.
We applied the proposed method with optional pa-
rameters and summarized the results with MAF-based
collapsing to prevent confusions with different parame-
ters. From the analysis of real data, we investigated
gene-gene interaction association between T2D and col-
lapsed rare variants. We report the top 10 gene pairs
and their characteristics in Table 2. In Table 2, WCVC is
Fig. 5 Result of simulation 1
Table 2 Top 10 gene combinations in the result
Rank Gene combination WCVC BA train BA test *p-value
1 ATP9A, DNAH17 9.924 0.572 0.572 5.00E-06
2 DNAH17, KARS 9.899 0.571 0.571 8.00E-06
3 CHD5, PALB2 9.893 0.571 0.570 1.00E-06
4 DNAH17, EPHB1 9.861 0.569 0.569 1.10E-05
5 ARHGEF16, CHD5 9.855 0.568 0.568 1.00E-06
6 DNAH17, TRPM8 9.848 0.568 0.568 1.70E-06
7 DNAH17, PTPRH, 9.844 0.568 0.568 1.40E-05
8 CARD10, CHD5 9.834 0.567 0.567 5.00E-06
9 CHD5, FAM149A 9.820 0.566 0.566 2.00E-06
10 CHD5, TRANK1 9.814 0.566 0.566 5.00E-06
*p-value is calculated by 1,000,000 permutations
Kwon et al. BMC Systems Biology 2018, 12(Suppl 2):19 Page 27 of 130
the weighted CVC, BA train is the training balanced ac-
curacy, and BA test is the testing balanced accuracy.
In Table 2, the values of WCVC are almost 10, which
means that gene combinations are selected in almost 10 CV
datasets. In other words, gene pairs in Table 2 may not be
randomly selected. Additionally, BA train and test are almost
the same and this implies that gene pairs may have associ-
ation with T2D. Among top 10 interactions identified by
GxGrare, SKAT identified ARHGEF16-CHD5 (p= 0.0301),
CARD10-CHD5 (p= 0.0009), CHD5-FAM149A (p= 0.0391),
ATP9A-CHD5 (p= 0.0064), CHD5-MLL5 (p= 0.0135), while
SPA detected no interactions. ATP9A-DNAH17, DNAH17-
KARS, CHD5-PALB2, DNAH17-EPHB1, DNAH17-TRPM8,
DNAH17-PTPRH were only identified by GxGrare.
Among gene pairs, some genes such as CHD5 and
DNAH17 have repeatedly appeared. One possible rea-
son is that these genes have a marginal effect. For ex-
amples of advanced analysis, we visualized the
interaction of top 1 gene pair and network diagram of
interactions in Fig. 6.
In Fig. 6 (a), the dark gray cell represents high risk (H)
and light gray cells represent low risk (L) in GMDR. One
possible explanation for this interaction pattern is that mu-
tations of rare variants in DNAH17 increase T2D risk, but
their effects are restricted by the mutations of rare variants
in the ATP9A gene. In Fig. 6 (b), each node represents a
single gene and the edge represents the association be-
tween gene pairs and T2D. In many network diagrams in
biology and other domains, hub nodes may have an im-
portant role in the property applied in the network con-
struction. In our case, the genes such as CHD5, DNAH17,
ATP9A, and CARD10 may have an important role in the
occurrence of T2D. These genes may have marginal
effects, but the existence of marginal effect does not
mean no interaction effects. For example, ATP9A and
DNAH17 show the interaction pattern in Fig. 6 (a).
A more advanced analysis is possible using the net-
work analysis methods.
Gene-gene interactions in this experiment would
represent the simultaneous occurrence of allelic variants
in diseased individuals or masking effect of a gene by an-
other. If more diseased individuals have a certain pair of
genetic variants, that pair is likely to have gene-gene
interaction associated with the disease of interest. Unfor-
tunately, the detected pairs had no reported biological
pathways to support the interaction between the genes.
Among the candidate hub genes, CACNA1H, CARD10,
FGFRL1, CADPS, ANK2, and MADD have literatures that
support their association with T2D; these genes have mar-
ginal association with the disease. Although not detected
as hubs, TRPM8, PALB2, AXIN1, and CUBN genes have
supporting literatures that confirm their association with
T2D. These genes have been summarized in Table 3.
Other genes on the list can be interpreted as candidate
genes with gene-gene interaction without single gene
based effects, since these genes have not been detected by
single gene based analysis.
Discussion and conclusion
In this paper, we propose a weight based collapsing frame-
work for rare variants association analysis that investigates
gene-gene interaction. Three collapsing schemes are sug-
gested through common weighting mechanism for each
rare variant. Of the two key findings, first is that the MAF
based collapsing method showed the best overall perform-
ance in the results of simulation data, in terms of power
(while preserving type I error), in our simulation studies
comparing SPA, SKAT and the three proposed collapsing
methods explained in detail in our methods section. This
result was somewhat surprising in that the simple collaps-
ing of variants with similar MAFs were able to find more
candidate interactions than other methods; other than the
SPA, the other two collapsing methods contain more
biological information that was expected to be advanta-
geous, however, was shown otherwise. The second finding
is that using the IG as evaluation measure showed higher
Fig. 6 Visualized interaction (a) and network diagrams of interactions (b)
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statistical power than using the BA as evaluation measure,
when using our MDR scheme. Many have coupled BA
with MDR analyses to report top interactions and bio-
logical validations have been performed for such interac-
tions. Since using the IG performed better than using BA
in terms of power, while preserving type I error, when ana-
lyzing our simulation datasets, we expect our findings
with the real data to be plausible candidates for early
gene-gene interactions. Entropy measures such as IG and
normalized mutual information (NMI) have shown better
performance than the BA to measure the classification
performance in the contingency table [21]. As compared
with BA, these entropy measures are less susceptible to
over-fitting and superior to classification error [34, 35]. As
stated in the results section, some of the findings were
already reported to have associations with the disease of
interest, and the rest of the genes in the list should be in-
vestigated through biological validation methods.
Our study presents a novel scheme to analyze the gene-
gene interaction of rare variants. Several weight collapsing
schemes have been compared and incorporation of IG as
evaluation measure has been added to MDR analysis. We
identified several interacted gene pairs and hub-genes that
are related to the disease of interest. Although the current
study compared three types of proposed collapsing schemes
and suggested one evaluation measure other than BA, our
approach illustrates examples of a practical way to improve
existing methods. In further studies, a universally optimal
weight collapsing scheme will be investigated. As public
biological databases accumulate, functional information
and conservation score information will be updated;
improved performances of collapsing methods using bio-
logical databases can be assumed. Moreover, our frame-
work can be easily expanded to utilize other types of future
annotations and to compare their performances as MDR
weights.
GxGrare is available at http://bibs.snu.ac.kr/software/
gxgrare which contains simulation data and documenta-
tion. Supported operating systems include Linux and OS X.
Additional file
Additional file 1: Figure S1–S9, detection probabilities of simulation
2~ 10. (DOCX 706 kb)
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CACNA1H (coding) Voltage-Dependent T-Type Calcium Channel Subunit Alpha-1H has a role in Type-1 diabetes [36].
CARD10 (intronic) CARD10 is a family member that interacts with BCL10 and activates NF-kappa B [37]. Suppression of NF-kappaB
activation blocks osteoclastic bone resorption during estrogen deficiency [38], and osteoporosis stems from an
imbalance in osteoclastic bone resorption with respect to osteoblastic bone formation [39].
FGRL1 (coding) Fibroblast Growth Factor Receptor-L1 expression in Pancreatic beta-cells has numerous reports in relation to T2D [40].
CADPS (coding) This gene encodes a novel neural/endocrine-specific cytosolic and peripheral membrane protein required for the
Ca2 + −regulated exocytosis of secretory vesicles [41]. The gene is known to be associated with Type-1 diabetes [42].
MADD (coding) Tumor necrosis factor alpha is a signaling molecule that interacts with one of two receptors on cells targeted for
apoptosis [43]. The gene is known to play a critical role in glucose-induced insulin secretion [44].
ANK2 (coding) This gene encodes a member of the ankyrin family of proteins that link the integral membrane proteins to the underlying
spectrin-actin cytoskeleton. The gene has been reported to be in relation with insulin and pancreatic islets in type-1
diabetes database [45, 46].
TRPM8 (coding) Mice lacking TRPM8 respond normally to a glucose challenge while exhibiting prolonged hypoglycemia in response
to insulin [47]. Relationship between brown adipose tissue, TRPM8 gene, and obesity & diabetes have been reported [48].
PALB2 (coding) This gene encodes a protein that may function in tumor suppression [49]. This gene is reported to be related to
Breast cancer and pancreatic cancer [50]. Pancreatic cancer and diabetes have close relations [51].
AXIN1 (coding) This gene encodes a cytoplasmic protein which contains a regulation of G-protein signaling domain and a disheveled
axin domain [52]. The genes is reported in the type-1 diabetes database.
CUBN (coding) Cubilin (CUBN) acts as a receptor for intrinsic factor-vitamin B12 complexes [53]. The gene is related to albuminuria
and is an important key factor of chronic kidney disease, especially in individuals with diabetes [54].
Kwon et al. BMC Systems Biology 2018, 12(Suppl 2):19 Page 29 of 130
About this supplement
This article has been published as part of BMC Systems Biology Volume 12
Supplement 2, 2018: Proceedings of the 28th International Conference on
Genome Informatics: systems biology. The full contents of the supplement
are available online at https://bmcsystbiol.biomedcentral.com/articles/
supplements/volume-12-supplement-2.
Authors’ contributions
MK and TP conceived and designed the study. MK carried out the simulation
and real data analysis. JY investigated the biological interpretation of
interactions. SL summarized the results. All authors read and approved the
final manuscript.
Ethics approval and consent to participate
KARE is are a part of Korean Genome Epidemiology Study (KoGES). In this
study, the exome sequencing data from 1037 samples of KARE study were
used. KARE dataset was used under the partnership of T2D-GENES. The study
using KARE samples was approved by two institutional review boards at
Seoul National University and the National Institute of Health, Korea.
Consent for publication
All participants of KARE were provided written informed consent.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Biomedical Informatics, Harvard Medical School, Boston
02115, MA, USA. 2Department of Statistics, Seoul National University, Seoul
08826, South Korea. 3Interdisciplinary program, Seoul National University,
Seoul 08826, South Korea.
Published: 19 March 2018
References
1. McPherson K, Steel C, Dixon J. Breast cancer-epidemiology, risk factors, and
genetics. BMJ: British Medical Journal. 2000;321(7261):624.
2. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends
Genet. 2001;17(9):502–10.
3. Manolio T, Collins F, Cox N, Goldstein D, Hindorff L, Hunter D, McCarthy M,
Ramos E, Cardon L, Chakravarti A. Finding the missing heritability of
complex diseases. Nature. 2009;461:747–53.
4. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T,
Lees CW, Balschun T, Lee J, Roberts R. Genome-wide meta-analysis increases
to 71 the number of confirmed Crohn's disease susceptibility loci. Nat
Genet. 2010;42(12):1118–25.
5. Pritchard JK. Are rare variants responsible for susceptibility to complex
diseases? Am J Hum Genet. 2001;69(1):124–37.
6. American Diabetes A. Diagnosis and classification of diabetes mellitus.
Diabetes Care. 2009;32(Suppl 1):S62–7.
7. Li B, Leal SM. Methods for detecting associations with rare variants for
common diseases: application to analysis of sequence data. Am J Hum
Genet. 2008;83(3):311–21.
8. Madsen BE, Browning SR. A groupwise association test for rare mutations
using a weighted sum statistic. PLoS Genet. 2009;5(2):e1000384.
9. Price AL, Kryukov GV, de Bakker PI, Purcell SM, Staples J, Wei L-J, Sunyaev
SR. Pooled association tests for rare variants in exon-resequencing studies.
Am J Hum Genet. 2010;86(6):832–8.
10. Morris AP, Zeggini E. An evaluation of statistical approaches to rare variant
analysis in genetic association studies. Genet Epidemiol. 2010;34(2):188–93.
11. Liu DJ, Leal SM. A novel adaptive method for the analysis of next-
generation sequencing data to detect complex trait associations with rare
variants due to gene main effects and interactions. PLoS Genet. 2010;6(10):
e1001156.
12. Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X. Rare-variant association testing
for sequencing data with the sequence kernel association test. Am J Hum
Genet. 2011;89(1):82–93.
13. Lee S, Emond MJ, Bamshad MJ, Barnes KC, Rieder MJ, Nickerson DA, Team
ELP, Christiani DC, Wurfel MM, Lin X. Optimal unified approach for rare-
variant association testing with application to small-sample case-control
whole-exome sequencing studies. Am J Hum Genet. 2012;91(2):224–37.
14. Ionita-Laza I, Makarov V, Buxbaum JD, Consortium AAS. Scan-statistic
approach identifies clusters of rare disease variants in LRP2, a gene linked
and associated with autism spectrum disorders, in three datasets. Am J
Hum Genet. 2012;90(6):1002–13.
15. Schaid DJ, Sinnwell JP, McDonnell SK, Thibodeau SN. Detecting genomic
clustering of risk variants from sequence data: cases versus controls. Hum
Genet. 2013;132(11):1301–9.
16. Lin W-Y. Association testing of clustered rare causal variants in case-control
studies. PLoS One. 2014;9(4):e94337.
17. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH.
Multifactor-dimensionality reduction reveals high-order interactions among
estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet.
2001;69(1):138–47.
18. Chung Y, Lee SY, Elston RC, Park T. Odds ratio based multifactor-
dimensionality reduction method for detecting gene-gene interactions.
Bioinformatics. 2007;23(1):71–6.
19. Lee SY, Chung Y, Elston RC, Kim Y, Park T. Log-linear model-based
multifactor dimensionality reduction method to detect gene–gene
interactions. Bioinformatics. 2007;23(19):2589–95.
20. Oh S, Lee J, Kwon M-S, Weir B, Ha K, Park T. A novel method to identify
high order gene-gene interactions in genome-wide association studies:
gene-based MDR. BMC bioinformatics. 2012;13(9):1.
21. Kwon M-S, Park M, Park T. IGENT: efficient entropy based algorithm for genome-
wide gene-gene interaction analysis. BMC Med Genet. 2014;7(Suppl 1):S6.
22. Lou X-Y, Chen G-B, Yan L, Ma JZ, Zhu J, Elston RC, Li MD. A generalized combinatorial
approach for detecting Gene-by-gene and gene-by-environment interactions with
application to nicotine dependence. Am J Hum Genet. 2007;80(6):1125–37.
23. Fan R, Lo S-H. A robust model-free approach for rare variants association
studies incorporating gene-gene and gene-environmental interactions. PLoS
One. 2013;8(12):e83057.
24. Gibson G. Rare and common variants: twenty arguments. Nat Rev Genet.
2012;13(2):135–45.
25. Cingolani P, Platts A, Wang LL, Coon M, Nguyen T, Wang L, Land SJ, Lu X,
Ruden DM. A program for annotating and predicting the effects of single
nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila
Melanogaster strain w1118; iso-2; iso-3. Fly. 2012;6(2):80–92.
26. Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human
missense mutations using PolyPhen-2. Current protocols in human genetics.
2013;7(20):21–7. 20. 41
27. Sim N-L, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server:
predicting effects of amino acid substitutions on proteins. Nucleic Acids
Res. 2012;40(W1):W452–7.
28. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K, Clawson
H, Spieth J, Hillier LW, Richards S. Evolutionarily conserved elements in
vertebrate, insect, worm, and yeast genomes. Genome Res. 2005;15(8):1034–50.
29. Sadri J, Diallo AB, Blanchette M. Predicting site-specific human selective
pressure using evolutionary signatures. Bioinformatics. 2011;27(13):i266–74.
30. Velez DR, White BC, Motsinger AA, Bush WS, Ritchie MD, Williams SM, Moore JH.
A balanced accuracy function for epistasis modeling in imbalanced datasets
using multifactor dimensionality reduction. Genet Epidemiol. 2007;31(4):306–15.
31. Goebel B, Dawy Z, Hagenauer J, Mueller JC: An approximation to the distribution
of finite sample size mutual information estimates. In: Communications, 2005 ICC
2005 2005 IEEE International Conference on: 16–20 May 2005 2005;
2005: 1102–1106 Vol. 1102.
32. Kwon M-S, Kim K, Lee S, Chung W, Yi S-G, Namkung J, Park T. GWAS-GMDR:
a program package for genome-wide scan of gene-gene interactions with
covariate adjustment based on multifactor dimensionality reduction. In:
bioinformatics and biomedicine workshops (BIBMW), 2011 IEEE international
conference on: 2011. IEEE. 2011:703–7.
33. Marchini J, Donnelly P, Cardon LR. Genome-wide strategies for detecting
multiple loci that influence complex diseases. Nat Genet. 2005;37(4):413–7.
34. Bush WS, Edwards TL, Dudek SM, McKinney BA, Ritchie MD. Alternative
contingency table measures improve the power and detection of
multifactor dimensionality reduction. Bmc Bioinformatics. 2008;9(1):238.
35. Namkung J, Kim K, Yi S, Chung W, Kwon M-S, Park T. New evaluation
measures for multifactor dimensionality reduction classifiers in gene–gene
interaction analysis. Bioinformatics. 2009;25(3):338–45.
Kwon et al. BMC Systems Biology 2018, 12(Suppl 2):19 Page 30 of 130
36. Khomula EV, Borisyuk AL, Viatchenko-Karpinski VY, Briede A, Belan PV, Voitenko
NV. Nociceptive neurons differentially express fast and slow T-type Ca2. Neural
plasticity. 2014;2014
37. Wang L, Guo Y, Huang W-J, Ke X, Poyet J-L, Manji GA, Merriam S,
Glucksmann MA, DiStefano PS, Alnemri ES. Card10 is a novel caspase
recruitment domain/membrane-associated guanylate kinase family member
that interacts with BCL10 and activates NF-κB. J Biol Chem. 2001;276(24):
21405–9.
38. Strait K, Li Y, Dillehay DL, Weitzmann MN. Suppression of NF-kappa B
activation blocks osteoclastic bone resorption during estrogen deficiency.
Int J Mol Med. 2008;21(4):521.
39. Peters M: Ranking Genome Wide Association Data by fusing Genomic and
Functional Information.
40. Silva PN, Altamentova SM, Kilkenny DM, Rocheleau JV. Fibroblast growth
factor receptor like-1 (FGFRL1) interacts with SHP-1 phosphatase at insulin
secretory granules and induces beta-cell ERK1/2 protein activation. J Biol
Chem. 2013;288(24):17859–70.
41. Hernández-Caballero ME, Arenas-Aranda DJ, Chávez-Torres R, Sierra-Ramírez
JA, Calzada-Mendoza CC. Impact of D-bifunctional protein deficiency on
telomere length and gene expression in a child. British Journal of Medicine
and Medical Research. 2013;3(2):351.
42. Speidel D, Salehi A, Obermueller S, Lundquist I, Brose N, Renström E,
Rorsman P. CAPS1 and CAPS2 regulate stability and recruitment of insulin
granules in mouse pancreatic β cells. Cell Metab. 2008;7(1):57–67.
43. Del Villar K, Miller CA. Down-regulation of DENN/MADD, a TNF receptor
binding protein, correlates with neuronal cell death in Alzheimer's disease
brain and hippocampal neurons. Proc Natl Acad Sci. 2004;101(12):4210–5.
44. Li L-c, Wang Y, Carr R, Haddad CS, Li Z, Qian L, Oberholzer J, Maker AV,
Wang Q, Prabhakar BS. IG20/MADD plays a critical role in glucose-induced
insulin secretion. Diabetes. 2014;63(5):1612–23.
45. Healy L, Ryan A, Carroll P, Ennis D, Crowley V, Boyle T, Kennedy M, Connolly
E, Reynolds J. Metabolic syndrome, central obesity and insulin resistance are
associated with adverse pathological features in postmenopausal breast
cancer. Clin Oncol. 2010;22(4):281–8.
46. Nishimura M, Yokoi N, Miki T, Horikawa Y, Yoshioka H, Takeda J, Ohara O, Seino
S. Construction of a multi-functional cDNA library specific for mouse pancreatic
islets and its application to microarray. DNA Res. 2004;11(5):315–23.
47. McCoy DD, Zhou L, Nguyen A-K, Watts AG, Donovan CM, McKemy DD.
Enhanced insulin clearance in mice lacking TRPM8 channels. Am J Physiol-
Endocrinology and Metabolism. 2013;305(1):E78–88.
48. Ma S, Yu H, Zhao Z, Luo Z, Chen J, Ni Y, Jin R, Ma L, Wang P, Zhu Z.
Activation of the cold-sensing TRPM8 channel triggers UCP1-dependent
thermogenesis and prevents obesity. J Mol Cell Biol. 2012;4(2):88–96.
49. Hoskins JW, Jia J, Flandez M, Parikh H, Xiao W, Collins I, Emmanuel MA, Ibrahim
A, Powell J, Zhang L. Transcriptome analysis of pancreatic cancer reveals a
tumor suppressor function for HNF1A. Carcinogenesis. 2014;35(12):2670–8.
50. Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylkäs K, Roberts J, Lee
A, Subramanian D, De Leeneer K, Fostira F. Breast-cancer risk in families with
mutations in PALB2. N Engl J Med. 2014;371(6):497–506.
51. Magruder JT, Elahi D, Andersen DK. Diabetes and pancreatic cancer: chicken
or egg? Pancreas. 2011;40(3):339–51.
52. Kishida S, Yamamoto H, Hino S-i, Ikeda S, Kishida M, Kikuchi A. DIX domains
of Dvl and Axin are necessary for protein interactions and their ability to
regulate β-catenin stability. Mol Cell Biol. 1999;19(6):4414–22.
53. Kozyraki R, Kristiansen M, Silahtaroglu A, Hansen C, Jacobsen C, Tommerup
N, Verroust PJ, Moestrup SK. The human intrinsic factor-vitamin B12
receptor, cubilin: molecular characterization and chromosomal mapping of
the gene to 10p within the autosomal recessive megaloblastic anemia
(MGA1) region. Blood. 1998;91(10):3593–600.
54. Acton A: Diabetes: New Insights for the Healthcare Professional: 2012
Edition. ScholarlyEditions 2012. •  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Kwon et al. BMC Systems Biology 2018, 12(Suppl 2):19 Page 31 of 130
